In 2006, Novocure chose Portsmouth, New Hampshire as the home for our North American operations. We value the region’s high-quality workforce, talent pipeline and strong commitment to innovation.
Since then, our U.S. team has worked hard to advance our global mission of extending survival in some of the most aggressive forms of cancer by developing and commercializing our innovative Tumor Treating Fields (TTFields) therapy. Significant investments in research and development have enabled us to reach more patients who can benefit from TTFields therapy and improve their experience using our therapy.
As we prepare for continued growth, we are deepening our regional ties. In 2024, we will open a state-of-the-art North American flagship facility in downtown Portsmouth.
Just as we have grown and evolved, so has New Hampshire’s life sciences sector. In 2021, the dynamic industry saw $4.3 billion in sales and accounted for 11,290 jobs, with average salaries of $130,848 per year, according to the New Hampshire Department of Business and Economic Affairs.
Now, we are teaming up with industry partners to help take the Granite State’s life sciences sector to the next level. In January 2024, we proudly joined New Hampshire Life Sciences (NHLS) as a founding member. NHLS, the state’s first industry-led life sciences association, is dedicated to improving patient lives and establishing New Hampshire as a leading life sciences hub.
NHLS is poised to champion New Hampshire’s cutting-edge life sciences sector and the top-tier talent it attracts, opening an exciting new chapter in the state’s economic landscape.
“Since establishing our North American headquarters in New Hampshire nearly two decades ago, Novocure has provided our unique therapy, Tumor Treating Fields, to thousands of patients with aggressive forms of cancer. New Hampshire’s life sciences industry fosters a culture of innovation that aligns with our patient-forward mission,” said William Doyle, our Executive Chairman. “Novocure is honored to join NHLS as its first Founding Member and is eager to work together to elevate the Granite State’s robust life sciences sector.”
Novo Nordisk, a global healthcare company, also joined us as an NHLS founding member.
“We are very pleased to announce Novocure and Novo Nordisk as our first Founding Members within the industry,” said Andrea Hechavarria, President and CEO of NHLS. “Both Novocure and Novo Nordisk are true champions for the life sciences community here in New Hampshire. Their strong support and belief in the value NHLS can bring to the state and the industry, have been instrumental in our successful launch.”
In a parallel stride, the Business and Industry Association (BIA), New Hampshire’s statewide chamber of commerce and leading nonpartisan business advocate, and the Massachusetts Biotechnology Council (MassBio), an industry leader for nearly 40 years, have joined the NHLS as Collaborative Partners.
